… , Europe and China, and meglumine antimoniate (MA) (syn. N–… Meglumine antimoniate has
been available in Brazil since … Meglumine antimoniate is presented commercially in the form …

… We conducted a quasi-experimental study to compare the response to meglumine antimoniate
in patients with localized cutaneous leishmaniasis from two endemic areas of Brazil that …

… the gold treatment standard, meglumine antimoniate, and with … mg/kg/day of IM meglumine
antimoniate (MA) for 10 days as … endemic areas where meglumine antimoniate is not available…

… of meglumine antimoniate (Glucantime) to pentamidine isethionate (pentamidine) in 80 patients
with Peruvian cutaneous leishmaniasis … diagnosis of cutaneous leishmaniasis. Inclusion …

… in 39.7% of the group receiving intralesional meglumine and in 72.9% of those on … meglumine
antimoniate is superior to topical paromomycin in the treatment of cutaneous leishmaniasis…

… Old World cutaneous leishmaniasis (CL) is a parasitic infection caused by Leishmania
species. … of combined cryotherapy and intralesional meglumine antimoniate (MA) (Glucantime®, …

… by Leishmania donovani but in cutaneous leishmaniasis only a … This study demonstrates
that meglumine antimoniate at 20 mg … of cutaneous leishmaniasis caused by L. major in Iran. …

… the treatment of cutaneous leishmaniasis with meglumine antimony in a reference service
in Mato Grosso State. A retrospective cohort of 151 patients with cutaneous leishmaniasis was …

… in Colombia where Leishmania panamensis and Leishmania guyanensis … cutaneous
leishmaniasis were randomized to directly observed treatment with meglumine antimoniate (20 mg …

… Cutaneous leishmaniasis is a serious public health problem in the developing world…
meglumine antimoniate alone and in combination for the initial treatment of cutaneous leishmaniasis…